Executive Profile*

Laura A. Brege

AgeTotal Calculated CompensationThis person is connected to 47 board members in 7 different organizations across 11 different industries.

See Board Relationships


Ms. Laura A. Brege served as the Chief Executive Officer and President of Nodality, Inc., from September 24, 2012 to July 2015. Ms. Brege has more than five decades of biotechnology and pharmaceutical industry experience with both privately-held and publicly-traded companies. Prior to joining Nodality in 2012, she served as an Executive Vice President of Corporate Affairs at Onyx Pharmaceuticals, Inc from January 2011 to December 31, 2011 and served as its Executive ...

Read Full Background

Corporate Headquarters*

170 Harbor Way
South San Francisco, California 94080

United States

Phone: 650-827-8000
Fax: 650-827-8001

Board Members Memberships*

Independent Director, Chairman of Audit Committee and Member of Nominating & Corporate Governance Committee
Independent Director
Independent Director and Member of Audit Committee


The University of Chicago
Ohio University
Ohio University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

Exercisable Options27,000
Unexercisable Options4,000
Total Number of Options31,000

Total Compensation*

Total Annual Cash Compensation$79,227
Total Calculated Compensation$395,978
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


James E. Brown D.V.M.Co-Founder, Chief Executive Officer, President and Director
DURECT Corporation
Rajat Rai Chief Executive Officer
Akorn, Inc.
Lars Marcher Chief Executive Officer, President and Member of Executive Board
Ambu A/S
A. J. Kazimi MBAFounder, Chairman, Chief Executive Officer and President
Cumberland Pharmaceuticals Inc.
Robert E. Abernathy Chairman, Chief Executive Officer, President and Member of Executive Committee
Halyard Health, Inc.
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact , please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.